Skip to main content

Table 1 Precision results of SARS-CoV-2 NTAb obtained using a 5 × 5 design (quintuplicate measurement for 5 consecutive days) expressed as coefficient of variation (CV, %)

From: Performance evaluation of an automatic chemiluminescence immune platform for SARS-CoV-2 neutralizing antibody after vaccination in real world

Measurand

Level, AU/mL

Design

Measured repeatability—CV, %

Intermediate precision—CV, %

Laboratory evaluation

Manufacturer’s claims

Laboratory evaluation

Manufacturer’s claims

NTAb

10.09

5 × 5

2.58

 ≤ 6.00

3.62

 ≤ 10.00

 

24.62

 

1.26

 ≤ 6.00

1.95

 ≤ 10.00

 

50.47

 

0.81

 ≤ 6.00

1.58

 ≤ 10.00